神経感染症

出版社： 中外医学社
著者：
発行日： 2017-09-10
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784498228788
電子書籍版： 2017-09-10 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

6,380 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

6,380 円(税込)

購入する

商品紹介

神経内科のエキスパートをめざす医師のための新シリーズ、好評第4弾！　Q&A形式の本文とワンポイントコラム「pearls」で神経感染症診療のポイントを効率的に学べるほか,各章の最後には症例を交え解説する「Case approach」など充実の内容.基礎から応用まで，診療の中で誰もが遭遇する疑問に明快に回答します．

目次

  • 神経感染症

    ―目次―

    I　神経感染症総論
    　1　神経感染症の分類
    　2　神経感染症の発生頻度
    　3　?感染症法による届け出は，
    　　　どんな神経感染症でするべきでしょうか？
    　4　神経感染症診療の手順
    　5　症候と画像診断から迫る神経感染症
    　6　神経感染症の病理

    II　細菌感染症
    　1　?細菌性髄膜炎の症状や発症経過はどのようなものでしょうか？
    　2　細菌性髄膜炎を疑った時にはどうしたらよいでしょうか？
    　3　?細菌性髄膜炎成人例の急性期治療は
    　　　どのようにしたらよいでしょうか？
    　4　?細菌性髄膜炎小児例の急性期治療は
    　　　どのようにしたらよいでしょうか？
    　5　?結核性髄膜炎の症状や発症経過は
    　　　どのようなものでしょうか？
    　6　結核性髄膜炎の診断はどのように行うのでしょうか？
    　7　結核性髄膜炎の治療はどのように行うのでしょうか？
    　8　脳膿瘍はどのように診断して治療したらよいでしょうか？
    　9　?腸管出血性大腸菌感染症による脳症は
    　　　どのように診断して治療したらよいでしょうか？
    　case approach　細菌性髄膜炎症例
    　case approach　結核性髄膜炎症例

    III　真菌感染症
    　1　クリプトコッカス髄膜脳炎はどのような病気で，
    　　　どのように診断・治療するのですか？
    　2　?アスペルギルス・ムコール症による中枢神経系感染症は
    　　　どのような病気で，どのように診断・治療するのですか？
    　3　カンジダ症による中枢神経系感染症はどのような病気で，
    　　　どのように診断・治療するのですか？
    　case approach　クリプトコッカス髄膜脳炎症例
    　case approach　ムコール症例

    IV　ウイルス感染症
    　1　?単純ヘルペス脳炎成人例の症状や発症経過は
    　　　どのようなものでしょうか？
    　2　?単純ヘルペス脳炎小児例の症状や発症経過は
    　　　どのようなものでしょうか？
    　3　?単純ヘルペス脳炎成人例の診断や治療は
    　　　どのようにしたらよいでしょうか？
    　4　?単純ヘルペス脳炎小児例の診断や治療は
    　　　どのようにしたらよいでしょうか？
    　5　?水痘帯状疱疹ウイルスによる中枢神経感染症は
    　　　どのような病気で，どのように診断・治療するのですか？
    　6　ヒトヘルペスウイルス6型脳炎はどのような病気で，
    　　　どのように診断・治療するのですか？
    　7　?サイトメガロウイルス脳炎の診断や治療は
    　　　どうしたらよいのでしょうか？
    　8　フラビウイルス感染症?日本脳炎・ウエストナイル脳炎は
    　　　どのような病気で，どのように診断・治療するのですか？
    　9　?インフルエンザ脳症の診断や治療は
    　　　どのようにしたらよいでしょうか？
    　10　?HTLV?1関連脊髄症（HAM）の診断と治療は
    　　　　どうしたらよいのでしょうか？
    　11　HIV感染症における中枢神経系感染症には
    　　　　どんな疾患があり，どのように治療するのでしょうか？
    　12　?エンテロウイルスD68に関連した急性弛緩性脊髄炎は
    　　　　どのような疾患でしょうか？
    　case approach　単純ヘルペス脳炎症例
    　case approach　水痘帯状疱疹ウイルス脊髄炎症例
    　case approach　インフルエンザ脳症成人例

    V　遅発性ウイルス感染症・プリオン病
    　1　?亜急性硬化性全脳炎の診断や治療は
    　　　どのようにしたらよいでしょうか？
    　2　進行性多巣性白質脳症の診断や治療は
    　　　どのようにしたらよいでしょうか？
    　3　プリオン病にはどのような疾患があり，
    　　　どのくらいの頻度でみられるのですか？
    　4　Creutzfeldt?Jakob病はどのように診断するのですか？
    　5　プリオン病の感染予防はどのようにするのですか？
    　case approach　家族性Creutzfeldt?Jakob病症例

    VI　その他の中枢神経系感染症
    　1　神経梅毒はどのように診断し，治療するのでしょうか？
    　2　ツツガムシ病はどのように診断し，治療するのでしょうか？
    　3　?吸虫症による中枢神経感染症はどのように診断し，
    　　　治療するのでしょうか？
    　4　?ライム病（神経ボレリア病）はどのように診断し，
    　　　治療するのでしょうか？
    　5　トキソプラズマ脳症はどのように診断し，
    　　　治療するのでしょうか？

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 神経感染症総論

P.10 掲載の参考文献
(1) John CC, Carabin H, Montano SM, et al. Global research priorities for infections that affect the nervous system. Nature. 2015;527:S178-86.
PubMed
(2) Whitley RJ. Herpes simplex encephalitis:adolescents and adults. Antiviral Res. 2006;71:141-8.
PubMed
(3) Whitley RJ, Soong SJ, Dolin R, et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977;297:289-94.
PubMed
(4) Kamei S, Takasu T. Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med. 2000;39:894-900.
PubMed
(5) 細菌性髄膜炎診療ガイドライン 2014 作成委員会(作成委員会委員長 亀井 聡, 他). In:細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014. p.1-123.
 
(6) Osborne AG. Infections of the brain. Diagnostic neuroradiology. St Louis:Mosby;1994. p.698-9.
 
(7) Masamed R, Meleis A, Lee EW, et al. Cerebral toxoplasmosis:case review and description of a new imaging sign. Clin Radiol. 2009;64, 560-3.
PubMed
P.13 掲載の参考文献
(1) Jmor F, Emsley HA, Fischer M, et al. The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virol J. 2008;5:134.
 
(2) Granerod J, Tam CC, Crowcroft NS, et al. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010;75:924-32.
PubMed
(3) Wada-IsoeK, Kusumi M, Kai T, et al. Epidemiological study of acute encephalitis in Tottori Prefecture, Japan. Eur J Neurol. 2008;15:1075-9.
 
(4) Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64:347-73.
 
(5) Hjalmarsson A, Blomqvist P, Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001:incidence, morbidity, and mortality. Clin Infect Dis. 2007;45:875-80.
PubMed
(6) Kamei S, Takasu T. Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med. 2000;39:894-900.
PubMed
(7) Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364:2016-25.
PubMed
P.16 掲載の参考文献
(1) 国立感染症研究所, 厚生労働省健康局結核感染症課. 侵襲性髄膜炎菌感染症の発生動向, 2013年第13週～2014年第52週. IASR. 2015;36:179-81.
 
P.25 掲載の参考文献
(1) 細菌性髄膜炎診療ガイドライン作成委員会, 編集. 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014.
 
(2) Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64:347-73.
 
(3) 厚生労働省ホームページ
 
P.47 掲載の参考文献
(1) 塩田宏嗣, 亀井 聡, 高須俊明. 単純ヘルペスウイルス脳炎成人例の臨床解析(第1報). 日大医学雑誌. 1998;57:484-97.
 
(2) 塩田宏嗣, 亀井 聡, 高須俊明. 単純ヘルペスウイルス脳炎成人例の臨床解析(第2報). 日大医学雑誌. 1998;57:498-515.
 
(3) Yoshikawa T, Ihira M, Suzuki K, et al. Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms. Arch Dis Child. 2000;82, 170-1.
 
(4) Noguchi T, Yoshiura T, Hiwatashi A, et al. CT and MRI findings of human herpesvirus 6-associated encephalopathy:comparison with findings of herpes simplex virus encephalitis. AJR Am J Roentgenol. 2010;194:754-60.
PubMed
(5) Osborne AG. Infections of the brain. Diagnostic neuroradiology. St Louis:Mosby;1994. p.698-9.
 
(6) Masamed R, et al. Cerebral toxoplasmosis:case review and description of a new imaging sign. Clin Radiol. 2009;64:560-3.
PubMed
(7) 細菌性髄膜炎診療ガイドライン 2014 作成委員会(作成委員会委員長 亀井 聡, 他). 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014.p.1-123.
 
(8) Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J infect. 2009;59:167-87.
 
(9) Verdon R, Chevret S, Laissy JP, et al. Tuberculous meningitis in adults:review of 48 cases. Clin Infect Dis. 1996;22:982-8.
PubMed
(10) Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis. 2009;18:251-8.
PubMed
(11) Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008;23:CD002244.
 
(12) Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-51.
PubMed
(13) Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease:2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.
 
(14) Ecevit IZ, Clancy CJ, Schmalfuss IM, et al. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients:a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis. 2006;42:1443-7.
 
(15) Tompkins M, Panuncialman I, Lucas P, et al. Spinal epidural abscess. J Emerg Med. 2010;39:384-90.
PubMed
(16) Patel AR, Alton TB, Bransford RJ, et al. Spinal epidural abscesses:risk factors, medical versus surgical management, a retrospective review of 128 cases. Spine J. 2014;14:326-30.
PubMed
(17) Pradilla G1, Ardila GP, et al. Epidural abscesses of the CNS. Lancet Neurol. 2009;8:292-300.
 
(18) 厚生労働科学研究費補助金難治性疾患克服研究事業. プリオン病及び遅発性ウイルス感染症に関する調査研究班・プリオン病のサーベイランスと感染予防に関する調査研究班. http://prion.umin.jp/prion/index.html
 
(19) 日詰正樹, 水澤英洋. プリオンとプリオン病. Brain Medical.2006;18:309-14.
Medical*Online
P.59 掲載の参考文献
(1) Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemics in Japan. Clin Infect Dis. 2002;35:512-7.
PubMed
(2) 高橋健太, 鈴木忠樹, 中島典子, 他. 脳炎・脳症の病理. Neuroinfection.2014;19:32-9.
 
(3) Love S, Perry A, Ironside J, et al. Greenfield's Neuropathology. 9th ed. CRC Press;2015.
 
(4) Ellison D, Love S, Chimelli L, et al. Neuropathology:A Reference Text of CNS Pathology. 3rd ed. Mosby;2013.
 
(5) Kradin RL. Diagnostic Pathology of Infectious Disease:Saunders;2010.
 

II 細菌感染症

P.66 掲載の参考文献
(1) Begg N, Cartwright KA, Cohen J, et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect. 1999;39:1-15.
 
(2) Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit:clinical manifestations, management and prognostic factors. Intensive Care Med. 2003;29:1967-73.
 
(3) van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-59.
PubMed
(4) Saez-Lorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003;361:2139-48.
 
(5) Kilpi T, Anttila M, Kallio MJ, et al. Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet. 1991;338:406-9.
PubMed
(6) Anderson J, Backer V, Voldsgaard P, et al. Acute meningococcal meningitis in children:analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group. J Infect. 1997;34:227-35.
 
(7) Kornelisse RF, Westerbeek CM, Spoor AB, et al. Pneumococcal meningitis inchildren:prognostic indicators and outcome. Clin Infect Dis. 1995;21:1390-7.
 
(8) Kaplan SL. Clinical presentations, diagnosis, and prognostic factors of bacterial men-ingitis. Infect Dis Clin North Am. 1999;13:579-94.
 
(9) Levy M, Wong E, Fried D. Diseases that mimic meningitis. Analysis of 650 lumbar puncture. Clin Pediatr(Phila). 1990;29:254-5, 258-61.
 
(10) 細菌性髄膜炎診療ガイドライン作成委員会, 編. 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014.
 
(11) Zoons E, Weisfelt M, de Gans J, et al. Seizures in adults with bacterial meningitis. Neurology. 2008 27;70(22 Pt 2):2109-15.
 
(12) 佐藤吉壮. 【細菌性髄膜炎の臨床と最新の治療】臨床症状 小児患者の症状と徴候. Clin Neurosci.2015;33:1232-6.
 
(13) Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine(Baltimore). 1998;77:313-36.
 
(14) Lorber B. Listeria monositogenes. In:Mandell GL, Bennett JE, Dolin R, editors:Principles and practice of infectious disease, 7th ed. Philadelphia:Elsevier Churchill Livingstone;2009, p.2707-14.
 
(15) Waterhouse R. A case of suprarenal apoplexy. Lancet 1911;1:577-8.
 
(16) Friderichsen C. Nebennierenapoplexie bei kleinen Kindern. Jahrb Kinderh. 1918;87:109-25.
 
P.74 掲載の参考文献
(1) 細菌性髄膜炎診療ガイドライン作成委員会, 編. 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014.
 
(2) Oostenbrink R, Moons KG, Donders AR, et al. Prediction of bacterial meningitis in children with meningeal signs:reduction of lumbar punctures. Acta Paediatr. 2001;90:611-7.
PubMed
(3) Lise N, Richard M, Nathan K. Meta-analysis of bacterial meningitis score validation studies. Arch Dis Child. 2012;97:799-805.
 
(4) Nigrovic LE, Kuppermann N, Malley R. Development and validation of a multivariate predictive model to distinguish bacterial from aseptic meningitis in children in the post-haemophilus influenza era. Pediatrics. 2002;110:712-9.
PubMed
(5) Lagi F, Bartalesi F, Pecile P, et al. Proposal for a new score-based approach to improve efficiency of diagnostic laboratory workflow for acute bacterial meningitis in adults. J Clin Microbiol. 2016;54:1851-4.
PubMed
(6) Hase R, Hosokawa N, Yaegashi M, et al. Bacterial meningitis in the absence of cerebrospinal fluid pleocytosis:A case report and review of the literature. Can J Infect Dis Med Microbiol. 2014;25:249-51.
PubMed
P.81 掲載の参考文献
(1) Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-84.
PubMed
(2) Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis:report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15:649-59.
PubMed
(3) 細菌性髄膜炎診療ガイドライン作成委員会, 編. 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014. p.1-123.
 
(4) Takahashi K, Ogawa K, Ishikawa H, et al. Hospital-based study of the distribution of pathogens in adult bacterial meningitis with underlying disease in Tokyo, Japan. Neurology and Clinical Neuroscience. 2017;5:8-17.
 
(5) de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549-56.
PubMed
(6) van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis:a meta-analysis of individual patient data. Lancet Neurol. 2010;9:254-63.
PubMed
P.87 掲載の参考文献
(1) 細菌性髄膜炎診療ガイドライン作成委員会, 編. 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014.
 
P.92 掲載の参考文献
(1) Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis:more questions, still too few answers. Lancet Neurol. 2013;12:999-1010.
PubMed
(2) Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningit by use of clinical and laboratory features. Lancet. 2002;360:1287-92.
 
(3) Vibha D, Bhatia R, Prasad K, et al. Validation of diagnostic algorithm to differentiate between tuberculous meningitis and acute bacterial meningitis. Clin Neurol Neurosurg. 2012;114:630-44.
 
(4) Gu J, Xiao H, Wu F, et al. Prognostic factors of tuberculous meningitis:a single-center study. Int J Clin Exp Med. 2015;8:4487-93.
 
(5) Erdem H, Ozturk-Engin D, Tireli H, et al. HAMSI scoring in the prediction of unfavorable outcomes from tuberculous meningitis:results of Haydarpasa-II study. J Neurol. 2015;262:890-8.
PubMed
P.101 掲載の参考文献
(1) Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis:pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21:243-61.
PubMed
(2) 中嶋秀人, 松木 充. 標準的神経治療:結核性髄膜炎 III診断と鑑別疾患(病原体の遺伝子診断を除く). 神経治療. 2015;32:520-3.
 
(3) Takahashi T, Tamura M, Takasu T. The PCR-based diagnosis of central nervous system tuberculosis:Up to date. Tuberc Res Treat. 2012;2012:831292.
PubMed
(4) 高橋輝行, 田村正人. 標準的神経治療:結核性髄膜炎 IV結核菌の遺伝子診断. 神経治療. 2015;32:524-8.
 
(5) Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis:a systematic review and meta-analysis. Lancet Infect Dis. 2003;3:633-43.
PubMed
(6) Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis:a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10:803-12.
PubMed
P.109 掲載の参考文献
(1) 日本結核病学会治療委員会. Kekkaku. 2014;89:683-90.
 
(2) Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis:more questions, still too few answers. Lancet Neurol. 2013;12:999-1010.
PubMed
(3) WHO. Treatment of tuberculosis guidelines, 4th ed. Geneva:World Health Organization, 2010.
 
(4) Thwaites GE, Lan NT, Dung NH, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis. 2005;192:79-88.
PubMed
(5) Thwaites GE, Bhavnani SM, Chau TT, et al. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother. 2011;55:3244-53.
PubMed
(6) Alffenaar JW, van Altena R, Bokkerink HJ, et al. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis. 2009;49:1080-2.
PubMed
(7) WHO treatment guidelines for drug-resistant tuberculosis, 2016 update.
 
(8) Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008;1.
PubMed
(9) Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-51.
PubMed
(10) Shukla R, Abbas A, Kumar P, et al. Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect. 2008;57:298-306.
PubMed
(11) Deshpande DH, Bharucha EP, Mondkar VP. Tuberculous meningitis in adults(a clinico-pathological study of 18 cases). Neurol India. 1969;17:28-34.
PubMed
(12) Dastur DK, Lalitha VS, Udani P, et al. The brain and meninges in tuberculous meningitis:gross pathology in 100 cases and pathogenesis. Neurol India. 1970;18:86-94.
PubMed
(13) Poltera AA, Templeton AC. Intracranial tuberculosis in Uganda:a post-mortem survey. Afr J Med Sci. 1973;4:343-9.
PubMed
(14) Thomas MD, Chopra JS, Banerjee AK, et al. Tuberculous meningitis(a clinicopathological study). Neurol India. 1977;25:26-34.
PubMed
(15) Thwaites GE, Macmullen-Price J, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis:an observational study. Lancet Neurol. 2007;6:230-6.
PubMed
(16) Schoeman JF, Van Zyl LE, Laubscher JA, et al. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 1997;99:226-31.
PubMed
(17) Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis:a randomized open label placebo controlled trial. J Neurol Sci. 2010;293:12-7.
 
(18) Schoeman JF, Janse van Rensburg A, Laubscher JA, et al. The role of aspirin in childhood tuberculous meningitis. J Child Neurol. 2011;26:956-62.
PubMed
(19) Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59:167-87.
 
(20) Azuma J, Ohno M, Kubota R, et al. NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis:a randomized controlled trial for pharmacogenetics-based therapy. Eur J Clin Pharmacol. 2013;69:1091-101.
PubMed
P.115 掲載の参考文献
(1) Brouwer MC, Tunkel AR, McKhann GM 2nd, et al. Brain abscess. N Engl J Med. 2014;371:447-56.
PubMed
(2) Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess:systematic review and meta-analysis. Neurology. 2014;82:806-13.
PubMed
(3) Reddy JS, Mishra AM, Behari S, et al. The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions:a report of 147 lesions. Surg Neurol. 2006;66:246-50.
PubMed
(4) Mathisen GE, Johnson JP. Brain abscess. Clin Infect Dis. 1997;25:763-79;quiz 780-1.
 
P.120 掲載の参考文献
(1) 五十嵐隆, 溶血性尿毒症症候群の診断・治療ガイドライン作成班, 編. 溶血性尿毒症症候群の診断・治療ガイドライン. 東京:東京医学社;2013.
 
(2) Colic E, Dieperink H, Titlestad K, et al. Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark:an observational study. Lancet. 2011;378:1089-93.
PubMed
(3) Takanashi J, Taneichi H, Misaki T, et al. Clinical and radiologic features of encephalopathy during 2011 E. coli O111 outbreak in Japan. Neurology. 2014;82:564-72.
PubMed
(4) Greinacher A, Friesecke S, Abel P, et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome:a prospective trial. Lancet. 2011;378:1166-73.
PubMed
(5) Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365:1073-86.
PubMed
P.124 掲載の参考文献
(1) Sigurdardottir B, Bjornsson OM, Jonsdottir KE, et al. Acute bacterial meningitis in adults:a 20-year overview. Arch Intern Med. 1997;157:425-30.
PubMed
(2) Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit:clinical manifestations, management and prognostic factors. Intensive Care Med. 2003;29:1967-73.
 
(3) van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-59.
PubMed
(4) Henney JE. Quick test for pneumonia. JAMA. 1999;282:1218.
 
(5) Genne D, Siegrist HH, Lienhard R. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay(Binax NOW). Int J Infect Dis 2006;10:124-8.
PubMed
(6) 細菌性髄膜炎診療ガイドライン作成委員会, 編. 細菌性髄膜炎診療ガイドライン 2014. 東京:南江堂;2014. p.89-97.
 

III 真菌感染症

P.135 掲載の参考文献
(1) Antinori S. New insights into HIV/AIDS-associated cryptococcosis. ISRN AIDS. 2013;471363.
PubMed
(2) Charlier C, Dromer F, Leveque C, et al. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One. 2008;3:e1950.
PubMed
(3) 深在性真菌症のガイドライン作成委員会, 編. 深在性真菌症の診断・治療ガイドライン 2014. 東京:協和企画;2014.
 
(4) Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50:291-322.
 
P.141 掲載の参考文献
(1) 小笠原淳一, 神田 隆. アスペルギルス症, ムコール症. In:辻 省次, 他編. 神経感染症を究める. 1版. 東京:中山書店;2014.p.226-33.
 
(2) Reinwald M, Buchheidt D, Hummel M, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One. 2013;8:e56706.
PubMed
(3) 深在性真菌症のガイドライン作成委員会, 編. 深在性真菌症の診断・治療ガイドライン 2014. 東京:協和企画;2014.
 
(4) Walia U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis:An update. J Infect Public Health. 2012;5:116-26.
 
P.146 掲載の参考文献
(1) Wisplinghoff H, Bischof T, Tallent SM, et al. Nosocomial bloodstream infectionsin US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-17.
 
(2) Parker JC jr, McCloskey JJ, Lee RS. Human cerebral candidosis--a postmortem evaluation of 19 patients. Human Pathol. 1981;12:23-8.
 
(3) Pendlebury WW, Perl DP, Munoz DG. Multiple microabscesses in the central nervous system:a clinicopathologic study. J Neuropathol Exp Neurol. 1989;48:290-300.
PubMed
(4) Sanchez-Portocarero J, Perez-Cecilia E, Corral O, et al. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis. 2000;37:169-79.
 
(5) Nguyen MH. Yu VL. Meningitis caused by Candida species:an emerging problem in neurosurgical patients. Clin Infect Dis. 1995;21:323-7.
PubMed
(6) Sanchez-Portocarero J, Martin Rabadan P, Saldana CJ. et al. Candida cerebrospinal fluid shunt infection:report of two new cases and review of the literature. Diagn Microbiol Infect Dis. 1994;20:33-40
 
(7) Voice RA, Bradley SF, Sangeorzan JA, et al. Chronic candidal meningitis:an uncom-mon manifestation of candidiasis. Clin Infect Dis. 1994;19:60-6.
 
(8) Geers TA, Gordon SM. Clinical significance of Candida species iso lated from cerebrospinal fluid following neurosurgery. Clin Infect Dis. 1999;28:1139-47.
 
(9) Casado JL. Quereda C, Oliva J, et al. Candidal meningitis in HIV infected patients:analysis of 14cases. Clin infect Dis. 1997;25:673-6.
 
(10) Smego RA Jr, Perfect JR, Durack DT. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev Infect Dis. 1984;6:791-801.
PubMed
(11) Nakayama H, Shibuya K, Kimura M, et al. Histopathological study of candidal infection in the central nervous system. Nippon Ishinkin Gakkai Zasshi. 2010;51:31-45.
 
P.153 掲載の参考文献
(1) 深在性真菌症のガイドライン作成委員会, 編. 深在性真菌症の診断・治療ガイドライン 2014. 東京:協和企画;2014.
 
(2) Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50:291-322.
 
(3) Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368:1291-302.
PubMed
(4) Galanis E, Macdougall L, Kidd S, et al. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis. 2010;16:251-7.
PubMed
(5) Okamoto K, Hatakeyama S, Itoyama S, et al. Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis. 2010;16:1155-7.
PubMed
P.159 掲載の参考文献
(1) Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis:A review of 929 reported cases. Clin Infect Dis. 2005;41:634-53.
PubMed
(2) Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe:Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology(ECMM)Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859-67.
 
(3) 深在性真菌症の診断・治療ガイドライン作成委員会, 編. 深在性真菌症の診断・治療ガイドライン 2014. 東京:協和企画;2014;p.42-3.
 
(4) Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis:the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25:215-29.
PubMed
(5) Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47:364-71.
PubMed
(6) van Burik JA, Hare RS, Solomon HF, et al. Posaconazole is effective as salvage therapy in zygomycosis:a retrospective summary of 91 cases. Clin Infect Dis. Epub 2006;42:e61-5.
 

IV ウイルス感染症

P.166 掲載の参考文献
(1) 高須俊明. III脳炎, 髄膜炎. In:森 良一, 川名 尚, 編. ヘルペスウイルス感染症. 東京:メディカルトリビューン;1986. p.100-15.
 
(2) 榊原隆次, 福武敏夫, 平山恵三. 単純ヘルペス脳炎における脳幹症状主体の病型について. 千葉医学. 1992;68:161-6.
 
(3) Love S, Wiley CA. Viral diseases. In:Graham D, Lanos PL, editors. Greenfields Neuropathology. Vol 2. 7th ed. London:Edward Arnold;2002. p.19-23.
 
(4) 塩田博嗣, 亀井 聡, 高須俊明. 単純ヘルペスウイルス脳炎成人例の臨床解析(第1報). I. 臨床像と治療病態の解析. II. 非単純ヘルペス脳炎との比較. 日大医誌. 1998;57:484-97.
 
(5) 高須俊明, 亀井 聡, 田村英二, 他. ヘルペス脳炎. 綜合臨床. 1984;11:2451-6.
 
(6) Whitley RJ, Soong SJ, Linneman C Jr, et al. Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982;247:317-20.
PubMed
(7) 深津玲子. 【高次脳機能障害のすべて】神経疾患と高次脳機能障害 脳炎と脳症. 神経内科. 2008;68:142-6.
 
P.171 掲載の参考文献
(1) Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-15.
PubMed
(2) Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361:1376-85.
PubMed
(3) 森島恒雄, 川名 尚, 平山宗宏. 新生児ヘルペス全国調査. 日児誌. 1989;93:1990-5.
 
(4) Torii Y, Kimura H, Ito Y, et al. Clinicoepidemiologic status of mother-to-child infections:a nationwide survey in Japan. Pediatr Infect Dis J. 2013;32:699-701.
PubMed
(5) Kimberlin DW, Baley J;Committee on fetus and newborn. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics. 2013;131:e635-64.
PubMed
(6) Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections:frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis. 1991;164:289-93.
PubMed
(7) Whitley RJ, Lakeman E. Herpes simplex virus infections of the central nervous system:therapeutic and diagnostic considerations. Clin Infect Dis. 1995;20:414-20.
 
(8) Whitley RJ, Gnann JW. Viral encephalitis:familiar infections and emerging pathogens. Lancet. 2002;359:507-13.
PubMed
(9) Landis BN, Vodicka J, Hummel T. Olfactory dysfunction following herpetic meningoencephalitis. J Neurol. 2010;257:439-43.
PubMed
(10) Ito Y, Ando Y, Kimura H, et al. Polymerase chain reaction-proved herpes simplex encephalitis in children. Pediatr Infect Dis J. 1998;17:29-32.
PubMed
(11) Hsieh WB, Chiu NC, Hu KC, et al. Outcome of herpes simplex encephalitis in children. J Microbiol Immunol Infect. 2007;40:34-8.
 
(12) Kimura H, Aso K, Kuzushima K, et al. Relapse of herpes simplex encephalitis in children. Pediatrics. 1992;89:891-4.
PubMed
(13) Ito Y, Kimura H, Yabuta Y, et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis. 2000;30:185-7.
PubMed
(14) De Tiege X, Rozenberg F, DesPortes V, et al. Herpes simplex encephalitis relapses in children:differentiation of two neurologic entities. Neurology. 2003;61:241-3.
 
(15) Kullnat MW, Morse RP. Choreoathetosis after herpes simplex encephalitis with basal ganglia involvement on MRI. Pediatrics. 2008;121:e1003-7.
PubMed
P.175 掲載の参考文献
(1) Olson LC, Buescher EL, Artenstein MS, et al. Herpesvirus infections of the human central nervous system. N Engl J Med. 1967;277:1271-7.
PubMed
(2) Illis LS, Merry RTG. Treatment of herpes simplex encephalitis. J R Coll Physicians Lond. 1972;7:34-44.
 
(3) Whitley RJ, Soong S-J, Dolin R, et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977;297:289-94.
PubMed
(4) Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2:707-11.
PubMed
(5) Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Eng J Med. 1986;314:144-9.
 
(6) McGrath N, Anderson NE, Croxson MC, et al. Herpes simplex encephalitis treated with acyclovir:diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;63:321-6.
PubMed
(7) Raschilas F, Wolff M, Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients:results of a multicenter study. Clin Infect Dis. 2002;35:254-60.
PubMed
(8) Kamei S, Takasu T. Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Internal Medicine. 2000;39:894-900.
PubMed
(9) VanLandingham KE, Marsteller HB, Ross GW, et al. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA. 1988;259:1051-3.
PubMed
(10) Dennett C, Klapper PE, Cleator GM. Polymerase chain reaction in the investigation of "relapse" following herpes simplex encephalitis. J Med Virol. 1996;48:129-32.
PubMed
(11) Yamada S, Kameyama T, Nagaya S, et al. Relapsing herpes simplex encephalitis:pathological confirmation of viral reactivation. J Neurol Neurosurg Psychiatry. 2003;74:262-4.
PubMed
(12) Valencia I, Miles DK, Melvin J, et al. Relapse of herpes encephalitis after acyclovir therapy:report of two new cases and review of the literature. Neuropediatrics. 2004;35:371-6.
PubMed
(13) Kennedy PG. Viral encephalitis. J Neurol. 2005;252:268-72.
PubMed
(14) Tunkel AR, Glaser CA, Bloch KC. The management of encephalitis:clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303-27.
 
(15) Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64:347-73.
 
(16) Tyler KL. Herpes simplex virus infections of the central nervous system:encephalitis and meningitis, including Mollaret's. Herpes. 2004;11(Suppl 2):57 A-64 A.
 
(17) Wang LX, Takayama-Ito M, Kinoshita-Yamaguchi H, et al. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1:mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment. Jpn J Infect Dis. 2013;66:404-10.
PubMed
(18) Ramos-Estebanez C, Lizarraga KJ, Merenda A. A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis:is timing critical for safety and efficacy? Antivir Ther. 2014;19:133-9.
 
P.184 掲載の参考文献
(1) 泉 達郎. 急性脳炎・急性脳症. こどもケア 6. 2012;23-9.
 
(2) 日本神経感染症学会. 単純ヘルペス脳炎診療ガイドライン. http://www.neuroinfection.jp/guideline001.html(平成27年1月2日アクセス)
 
(3) 森島恒雄, 川名 尚, 平山宗宏. 新生児ヘルペス全国調査. 日児誌. 1989;93:1990-5.
 
(4) Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections:frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis. 1991;164:289-93.
PubMed
(5) Kneen R, Michael BD, Menson E, et al;National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in children-Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012;64:449-77.
 
(6) 細矢光亮. 抗ウイルス薬の使い方. 小児科診療. 2010;73:209-12.
 
(7) Tunkel AR, Glaser CA, Bloch KC, et al. Infectious Diseases Society of America. The management of encephalitis:clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303-27.
 
(8) アシクロビル点滴静注用 250mg 添付文書(2013年11月改訂. 第10版)
 
(9) Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues:mechanisms, prevalence, and management. Antimicrob Chemother. 2011;55:459-72.
PubMed
(10) Ward KN, Ohrling A, Bryant NJ, et al. Herpes simplex serious neurological disease in young children:incidence and long-term outcome. Arch Dis Child. 2012;97:162-5.
PubMed
(11) Abel L, Plancoulaine S, Jouanguy E, et al. Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J Pediatr. 2010;157:623-9.
PubMed
(12) O'Riordan DP, Golden WC, et al. Herpes simplex virus infections in preterm infants. Pediatrics. 2006;118:e1612-20.
PubMed
(13) Kimura H, Ito Y, Futamura M, et al. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol. 2002;67:349-53.
PubMed
(14) Martinez-Torres F, Menon S, Pritsch M, et al:GACHE Investigators. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis(GACHE):a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial[ISRCTN45122933]. BMC Neurol. 2008;8:40. doi:10.1186/1471-2377-8-40.
 
(15) Nakano A, Yamasaki R, Miyazaki S, et al. Beneficial effect of steroid pulse therapy on acute viral encephalitis. Eur Neurol. 2003;50:225-9.
 
(16) Venturini E, Chiappini E, Fonda C, et al. Herpes simplex encephalitis with occipital localization in an infant:a different route of entry in the brain system? Pediatr Neurol. 2013;48:463-5.
 
(17) Red Book:2006 report of the Committee on Infectious Diseases. ELK Grove Village, IL:Amirican Academy of Pediatrics 2006.
 
(18) Meadows JT, et al. Acyclovir use in sick infants. Pediatr Emerg Care. 2010;26:495-8.
PubMed
P.191 掲載の参考文献
(1) Echevarria JM, Casas I, Martinez-Martin P, et al. Infections of the nervous system caused by varicella-zoster virus:a review. Intervirology. 1997;40:72-84.
 
(2) Kupila L, Vuorinen T, Vainionpaa R, et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology. 2006;66:75-80.
 
(3) 中嶋秀人, 細川隆史, 山根一志, 他. 皮疹を伴わなかった水痘・帯状ヘルペスウイルスによる髄膜脳炎の1例. 神経内科.2011;74:512-5.
 
(4) Gilden D, Cohrs RJ, Mahalingam R, et al. Varicella zoster virus vasculopathies:diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8:731-40.
PubMed
(5) Solomon T, Michael BT, Smith PE, et al. Management of suspected viral encephalitis in adults:Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64:347-73.
 
P.197 掲載の参考文献
(1) Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis:clinical features and relationship to HHV6. Neurology. 2007;69:156-65.
PubMed
(2) Hill JA, Koo S, Guzman Suarez BB, et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis:a cohort analysis. Biol Blood Marrow Transplant. 2012;18:1638-48.
PubMed
(3) Ogata M, Satou T, Kadota J, et al. Human herpesvirus 6(HHV-6)reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation:a multicenter, prospective study. Clin Infect Dis. 2013;57:671-81.
PubMed
(4) Kawamura Y, Sugata K, Ihira M, et al. Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation. J Clin Virol. 2011;51:12-9.
PubMed
(5) Ogata M, Kikuchi H, Satou T, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation:incidence and clinical significance. J Infect Dis. 2006;193:68-79.
PubMed
(6) Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated human herpesvirus 6:questions and answers. Rev Med Virol. 2012;22:144-55.
PubMed
(7) Tanaka-Taya K, Sashihara J, Kurahashi H, et al. Human herpesvirus 6(HHV-6)is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol. 2004;73:465-73.
 
(8) Miura H, Kawamura Y, Kudo K, et al. Virological analysis of inherited chromosomally integrated human herpesvirus-6 in three hematopoietic stem cell transplant patients. Transpl Infect Dis. 2015;17:728-31.
PubMed
(9) Zerr DM, Gupta D, Huang ML, et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:309-17.
PubMed
P.202 掲載の参考文献
(1) 造血細胞移植ガイドライン サイトメガロウイルス感染症. 第2版. JSTHC monograph 31, 2011.
 
(2) Silva CA, Oliveira AC, Vilas-Baas L, et al. Neurologic cytomegalovirus complications in patients with AIDS:retrospective review of 13 cases and review of the literature. Rev Inst Med Trop Sao Paulo. 2010;52:305-10.
 
(3) 岸田修二. 診断と治療のTopics. AIDSの中枢神経合併症 Up-Date. HIV感染症とAIDSの治療. 2011;2;43-58.
 
(4) 鈴木 裕, 亀井 聡, 田村正人, 他. 免疫異常のない健常成人に起こったサイトメガロウイルス脳炎. 臨床神経学. 1990;30:168-73.
 
P.206 掲載の参考文献
(1) 国立感染症研究所 感染症疫学センターホームページ「感染症流行予測調査・日本脳炎」 http://www.nih.go.jp/niid/ja/diseases/na/je.html
 
(2) Konishi E, Kitai Y, Tabei Y, et al. Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program. Vaccine. 2010;28:2664-70.
 
(3) Centers for Disease Control and Prevention. West Nile virus http://www.cdc.gov/westnile/statsmaps/index.html
 
(4) 平石克平, 松原義雄, 角田孝穂. 神経進歩. 1967;11:69-88.
 
(5) Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-9.
PubMed
P.211 掲載の参考文献
(1) Morishima T, Togashi T, Yokota S, et al;Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512-7.
 
(2) インフルエンザ脳症ガイドライン. 岡山大学小児科 HP等 http://www.okayama-u.ac.jp/user/pedhome/download/IAE_guideline_2009.pdf
 
(3) Nagao T, Morishima T, Kimura H, et al. Prognostic factors in influenza-associated encephalopathy. Pediatr Infect Dis J. 2008;27:384-9.
PubMed
(4) Nakazawa M, Akasaka M, Hasegawa T, et al. Efficacy and safety of fosphenytoin for acute encephalopathy in children. Brain Dev. 2015;37:418-22.
PubMed
(5) Okumura A, Nakagawa S, Kawashima H, et al. Deaths associated with pandemic(H1N1)2009 among children, Japan, 2009-2010. Emerg Infect Dis. 2011;17:1993-2000.
PubMed
P.217 掲載の参考文献
(1) Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy:analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1995;1:50-61.
PubMed
(2) Nozuma S, Matsuura E, Matsuzaki T, et al. Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis. PLoS One. 2014;9:e86144.
PubMed
(3) Izumo S, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy:a multicenter, randomized, double-blind, controlled trial. Neurology 1996;46:1016-21.
PubMed
(4) Matsuura E, Yoshimura A, Nozuma S, et al. Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis(HAM/TSP). BMC Neurol. 2015;15:275.
 
(5) Matsuura E, Umehara F, Nose H, et al. Inclusion body myositis associated with human T-lymphotropic virus-type I infection:eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol. 2008;67:41-9.
PubMed
P.226 掲載の参考文献
(1) Schouten J, Cinque P, Gisslen M, et al. HIV-1 infection and cognitive impairment in the cART era;a review. AIDS. 2011;25:561-75.
 
(2) 鈴木直人, 西萩 恵, 近藤正樹, 他. 厚生労働科学研究費補助金エイズ対策研究事業「NeuroAIDS の発症病態と治療法の開発を目指した長期フォローアップ体制の構築研究」班(班長 中川正法):HIV 感染者高次脳機能評価バッテリーの作成, 平成18年度総括・分担研究報告書. 7-14, 2007.
 
(3) Nightingale S, Winston A, Letendre S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13:1139-51.
PubMed
(4) http://www.uptodate.com/contents/hiv-associated-neurocognitive-disorders-epidemiology-clinical-manifestations-and-diagnosis
 
(5) Letendre S, et al. 17th Conference on Retroviruses and Oppoturnistic Infections, 2010, Abstract 172.
 
P.230 掲載の参考文献
(1) 豊福悦史, 益田大幸, 谷口留美, 他. エンテロウイルスD68型が検出された, 急性弛緩性脊髄炎を含む8症例-さいたま市. IASR. 2015;36:226-7.
 
(2) 筒井理華, 武差愛美, 坂 恭平, 他. エンテロウイルスD68型が検出された麻痺症状を呈する小児症例を含む2症例-青森県. IASR. 2016;37:12-3.
 
(3) Messacar K, Schreiner TL, Maloney JA, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015;385:1662-71.
PubMed
(4) Greninger AL, Naccache SN, Messacar K, et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA(2012-14):a retrospective cohort study. Lancet Infect Dis. 2015;15:671-82.
PubMed
(5) Van Haren K, Ayscue P, Waubant E, et al. Acute flaccid myelitis of unknown etiology in California, 2012-2015. JAMA. 2015;314:2663-71.
PubMed
(6) 伊藤健太, 堀越裕歩, 舟越 優, 他. エンテロウイルスD68型が検出された小児4症例-東京都. IASR. 2015;36:193-5.
 
(7) 改田 厚, 入谷展弘, 山元誠司, 他. エンテロウイルスD68型の再出現と系統樹解析(2010～2015年)-大阪市. IASR. 2015;36:247-8.
 
(8) 幾瀬 樹, 丸山 馨, 布施理子, 他. 気管支喘息発作の急増とエンテロウイルスD68型陽性-鶴岡市. IASR. 2015;36:248-9.
 
(9) 藤井慶樹, 則常浩太, 八島加八, 他. 喘息症状を呈する患者からのエンテロウイルス68型(EV-D68)の検出-広島市. IASR. 2015;36:249-50.
 
(10) 伊藤卓洋, 中村晴奈, 東 礼次郎, 他. 2015年秋における小児の喘息発作入院増加とエンテロウイルスD68型流行との関連-三重県津市. IASR. 2015;36:250-2.
 
(11) 豊福悦史, 益田大幸, 谷口留美, 他. 喘息様症状での入院者数とエンテロウイルスD68型流行との関連-さいたま市. IASR. 2016;37:13-4.
 
(12) 川村和久, 岡本道子, 押谷 仁. 短期間の地域流行が示唆されたエンテロウイルスD68型検出の小児4症例-仙台市. IASR. 2016;37:14-5.
 
(13) 是松聖悟, 三浦克志, 長谷川俊史, 他. エンテロウイルスD68型流行期における小児気管支喘息発作例の全国調査. IASR. 2016;37:31-3.
 
(14) 国立感染症研究所感染症疫学センター, ウイルス第二部:エンテロウイルスD68型(EV-D68)に関する国内の疫学状況のまとめ(更新)(2016年1月20日現在). IASR.2016;37:33-5.
 
P.238 掲載の参考文献
(1) 中里良彦, 二宮充喜子, 吉丸公子, 他. 高度の四肢麻痺を呈した herpes zoster myelitis の1例-本邦報告28例のまとめ-. 神経内科. 2005;62:487-93.
 
(2) Takahashi T, Tamura M, Miki K, et al. Varicella zoster virus myelitis in two elderly patients:diagnostic value of nested polymerase chain reaction assay and antibody index for cerebrospinal fluid specimens. Case Rep Neurol. 2013;5:81-90.
PubMed
(3) 犬飼 晃, 片山泰司, 見城昌邦, 他. 抗体価指数による髄腔内抗体産生の評価が病因診断確定に有用であった zoster sine herpete にともなう脊髄炎の1例. 臨床神経. 2010;50:634-40.
 
(4) Gregoire SM, van Pesch V, Goffette S, et al. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry. 2006;77:938-42.
PubMed
(5) Takahashi T, Tamura M, Takasu T. Diagnostic value of a "wide-range" quantitative nested real-time PCR assay for varicella zoster virus myelitis. J Med Virol. 2013;85:2042-55.
PubMed
P.241 掲載の参考文献
(1) 森島恒雄. インフルエンザ脳症ガイドライン【改訂版】. 小児科臨床. 2009;62:2483-528.
Medical*Online

V 遅発性ウイルス感染症・プリオン病

P.249 掲載の参考文献
(1) Garg RK. Subacute sclerosing panencephalitis. J Neurol. 2008;255:1861-71.
PubMed
(2) 堀田 博. 亜急性硬化性全脳炎(SSPE)2. 成因と発症機構. In:厚生労働省科学研究費補助金難治性疾患克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」, 編. プリオン病と遅発性ウイルス感染症. 東京:金原出版;2010. p.261-9.
 
(3) Jabbour JT, Garcia JH, Lemmi H, et al. Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases. JAMA. 1969;207:2248-54.
PubMed
(4) Lakshmi V, Malathy Y, Rao RR. Serodiagnosis of subacute sclerosing panencephalitis by enzyme linked immunosorbent assay. Indian J Pediatr. 1993;60:37-41.
PubMed
(5) Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis:an update. Dev Med Child Neurol. 2010;52:901-7.
PubMed
(6) Hosoya M, Mori S, Tomoda A, et al. Parmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrob Agents Chemother. 2004;48:4631-5.
 
P.254 掲載の参考文献
(1) Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus:clinical features and pathogenesis. Lancet Neurol. 2010;9:425-37.
PubMed
(2) 厚生労働科学研究費補助金 難治性疾患等克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」, 編. 進行性多巣性白質脳症(progressive multifocal leukoencephalopathy:PML)診療ガイドライン 2013. http://prion.umin.jp/file/PML2013.pdf
 
(3) http://prion.umin.jp/file/result_virus2014/19.pdf
 
(4) http://prion.umin.jp/file/result_virus2014/20.pdf
 
(5) Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012;366:1870-80.
 
P.262 掲載の参考文献
(1) Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133:3043-57.
PubMed
(2) Hamaguchi T, Kitamoto T, Sato T, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology. 2005;64:643-8.
PubMed
(3) Jin K, Shiga Y, Shibuya S, et al. Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology. 2004;62:502-5.
PubMed
(4) Yamada M, Tomimitsu H, Yokota T, et al. Involvement of the spinal posterior horn in Gerstmann-Straussler-Scheinker disease(PrP P102L). Neurology. 1999;52:260-5.
PubMed
(5) Ladogana A, Sanchez-Juan P, Mitrova E, et al. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol. 2009;256:1620-8.
PubMed
(6) Nakamaura Y, Ae R, Takumi I, et al. Descriptive epidemiology of prion disease in Japan:1999-2012. J Epidemiol. 2015;25:8-14.
PubMed
P.270 掲載の参考文献
(1) Nakamura Y, Ae R, Takumi I, et al. Descriptive epidemiology of prion disease in Japan:1999-2012. J Epidemiol. 2015;25:8-14.
 
(2) Yamada M [Surveillance of prion diseases:analysis of 409 patients]. Rionsho Shinkeigaku. 2003;43:806-9.
PubMed
(3) www.am.nagasaki-u.ac.jp/prion-cjd/prion/
 
(4) www.prion.med.tohoku.ac.jp/geneticanalysis.thml
 
(5) Masters CL, Harris JO, Gajdusek DG, et al. Creutzfeldt-Jakob disease:patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177-88.
 
(6) Global surveillance, diagnosis, and therapy of human transmissible spongiform encephalopathies. Report of a WHO consultation;9-11 February 1998
 
(7) WHO. The revision of the surveillance case definition for variant Creutzfeldt-Jakob disease(vCJD). 2001.
PubMed
(8) プリオン病と遅発性ウイルス感染症, 厚生労働科学研究費補助金難治性疾患克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」, 編. 東京:金原出版;2010.
 
P.273 掲載の参考文献
(1) Diack AB, Head MW, McCutcheon S, et al. Variant CJD 18 years of research and surveillance. Prion. 2014;8:286-95.
PubMed
(2) Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18:901-7.
PubMed
(3) http://www.who.int/bloodproducts/tablestissueinfectivity.pdf
 
(4) Rutala WA, Weber DJ;Society for Healthcare Epidemiology of America. Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol. 2010;31:107-17.
PubMed
(5) プリオン病感染予防ガイドライン(2008年版), 厚生労働科学研究費補助金・難治性疾患克服研究事業 プリオン病及び遅発性ウイルス感染症に関する調査研究班(水澤英洋班長), 2008.
 

VI その他の中枢神経系感染症

P.284 掲載の参考文献
(1) 池口邦彦. 神経梅毒. In:アクチュアル脳・神経疾患の臨床 神経感染症を極める. 1版. 東京:中山書店;2014.p.208-15.
 
(2) Bash S, Hathout GM, Cohen S. Mesiotemporal T2-weighted hyperintensity:neurosyphilis mimicking herpes encephalitis. Am J Neuroradiol. 2001;22:314-6.
PubMed
(3) Gurses C, Kurtuncu M, Jirsch J, et al. Neurosyphilis presenting with status epilepticus. Epileptic Disord. 2007:9:51-6.
PubMed
(4) Sinha S, Harish T, Taly AB, et al. Symptomatic seizures in neurosyphilis:an experience from a university hospital in south India. Seizure. 2008;17:711-6.
PubMed
(5) Centers for Disease Control Prevention, et al. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2006;55:1-94.
 
P.290 掲載の参考文献
(1) 宮村定男. 恙蟲病研究夜話. 新潟:考古堂書店;1988.
 
(2) 今野卓哉, 藤田信也. 寄生虫と神経系-ツツガムシと神経系-. 神経内科. 2012;77:233-7.
 
(3) 藤田信也. 忘れてはいけない感染症-ツツガムシ病-. Neuroinfection. 2015;20:40-3.
 
P.298 掲載の参考文献
(1) Chai J-Y. Paragonimiasis. In:Garcia HH, Tanowiz HB, Del Brutto OH. editors. Handbook of Clinical Neurology, Vol.114(3rd series). Neuroparasitology and Tropical Neurology. Amsterdam:Elsevier;2013. p.283-96.
 
(2) Oh SJ. Cerebral and spinal paragonimiasis:a histopathological study. J Neurol Sci. 1969;9:205-36.
PubMed
(3) 鶴岡純一郎, 三宅哲雄, 宮地悠輔, 他. 脳病変を契機に診断に至ったウエステルマン肺吸虫による脳肺吸虫症の1例. 小児感染免疫. 2012;24:19-23.
 
(4) Coyle CM. Schistosomiasis of the nervous system. In:Garcia HH, Tanowiz HB, Del Brutto OH. editors. Handbook of Clinical Neurology, Vol.114(3rd series). Neuroparasitology and Tropical Neurology. Amsterdam:Elsevier;2013. p.271-81.
 
(5) 林 正高. 2. 2)日虫脳症の紹介. In:日本住血吸虫症 特に脳症型・肝脾腫型を中心に. 名古屋:三恵社;2015. p.10-3.
 
(6) 伊藤研悠, 大脇義宏. 住血吸虫性脊髄炎の1例. J Tohkai Spinal Surg. 2009;23:23-7.
 
P.305 掲載の参考文献
(1) 橋本喜夫. 北海道のライム病の発生状況と症例-自験113例の検討. IASR. 2011;32:218-9.
 
(2) 白井慎一, 佐々木秀直. 神経ボレリア症 ライム病. In:辻 省治, 他編. アクチュアル脳・神経疾患の臨床 神経感染症を究める. 1版. 東京:中山書店;2015. p.202-7.
 
(3) Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis:clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134.
 
(4) Ljostad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis:a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;8:690-5.
PubMed
P.311 掲載の参考文献
(1) Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-76.
PubMed
(2) 小林泰一郎. トキソプラズマ症. In:水澤英洋, 他編. 別冊日本臨牀 新領域別症候群シリーズ26 神経症候群. 第2版. 大阪:日本臨牀社;2013. p.883-7.
 
(3) 狩野繁之. トキソプラズマ症. In:舘田一博, 他編. 別冊日本臨牀 新領域別症候群シリーズ24 感染症症候群. 第2版. 上. 大阪:日本臨牀社;2013. p.654-7.
 
(4) 厚生労働省・熱帯病治療薬研究班(http://trop-parasit.jp/index.html)寄生虫症薬物治療の手引き-2016- 改訂 9.0版. p.27-30.
 
(5) 柳町徳春. トキソプラズマ脳炎. In:青木茂樹, 他編. 新版よくわかる脳 MRI 東京:秀潤社;2006. p.462-3.
 
(6) 齋藤有紀, 松永晶子, 米田 誠. トキソプラズマ脳炎. In:水澤英洋, 他編. 神経感染症を究める 東京:中山書店;2014. p.240-4.
 

書評

最近チェックした商品履歴

Loading...